1Stock1.com
Google
 
1Stock1 Home
Financial Ratios
Mutual Fund Investing Terms
Option Trading Terms 
Stock Investing Terms
Albireo Pharma, Inc. (ALBO) Yearly Returns
 
     Year
  Beginning Price
  Ending Price
  Gain or Loss
  Percent Gain or Loss
2008
23.23
4.82
-18.41
-79.25%
2009
4.82
4.34
-0.48
-9.96%
2010
4.34
1.83
-2.51
-57.83%
2011
1.83
0.61
-1.22
-66.67%
2012
0.61
0.5875*
-0.0225
-3.69%
2013
2.35
2.28
-0.07
-2.98%
2014
2.28
1.33
-0.95
-41.67%
2015
1.33
0.3426
-0.9874
-74.24%
2016
0.3426
0.591*
0.2484
72.50%
2017
17.73
25.60
7.87
44.39%
2018
25.60
24.53
-1.07
-4.18%
2019
24.53
25.42
0.89
3.63%
2020
25.42
37.51
12.09
47.56%
2021
37.51
23.29
-14.22
-37.91%
2022
23.29
21.61
-1.68
-7.21%
2023
21.61
52.00*
30.39
140.63%
*The 2012 ending price for Albireo Pharma has been adjusted for a 1 for 4 reverse stock split.
*The 2016 ending price for Albireo Pharma has been adjusted for a 1 for 30 reverse stock split.
*In 2023, Ipsen (IPSEY) acquired Albireo Pharma (ALBO) for $42 in cash and a $10 deferred cash payment upon approval of the drug Bylvay by the FDA.
Calculations do not reflect any dividends paid or any stock spinoffs from original stock. Taxes and commissions are not factored into calculations. Data is property of 1stock1 and written permission must be granted before redistributing any data (in part or in whole).
Disclaimer/Contact Us
Stock Performance Guide         
Yearly Stock Returns Index     
Back to Yearly Stock Returns Index
Articles
From
1stock1.com